Nanodrug Delivery Strategies to Signaling Pathways in Alopecia.
Mol Pharm
; 20(11): 5396-5415, 2023 11 06.
Article
em En
| MEDLINE
| ID: mdl-37817669
ABSTRACT
Over 50% of the global population suffers from hair loss. The mixed results in the treatment of hair loss reveal the limitations of conventional commercial topical drugs. One the one hand, the definite pathogenesis of hair loss is still an enigma. On the other hand, targeted drug carriers ensure the drug therapeutic effect and low side effects. This review highlights the organization and overview of nine crucial signaling pathways associated with hair loss, as well as the development of nanobased topical delivery systems loading the clinical drugs, which will fuel emerging hair loss treatment strategies.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Alopecia
/
Nanopartículas
Limite:
Humans
Idioma:
En
Revista:
Mol Pharm
Ano de publicação:
2023
Tipo de documento:
Article